Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report

BACKGROUND: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin’s lymphoma. Standard first-line treatment for this aggressive subtype comprises the anti-CD20 antibody rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone. If patients receiving such tr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Med Case Rep
Asıl Yazarlar: Jurczak, Wojciech, Bryk, Agata Hanna, Mensah, Patrycja, Gałązka, Krystyna, Trofimiuk–Müldner, Małgorzata, Wyrobek, Łukasz, Sawiec, Anna, Skotnicki, Aleksander B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868005/
https://ncbi.nlm.nih.gov/pubmed/27178351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0875-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller